Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.360
- -0.790-7.78%
Close Dec 13 16:00 ET
- 9.480
- +0.120+1.28%
Post 17:55 ET
2.80BMarket Cap-27.53P/E (TTM)
9.910High9.295Low4.10MVolume9.850Open10.150Pre Close38.72MTurnover1.67%Turnover RatioLossP/E (Static)298.81MShares14.57052wk High15.65P/B2.30BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM6.06%Amplitude1.765Historical Low9.442Avg Price1Lot Size
About Amicus Therapeutics Company
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Company Profile
SymbolFOLD
Company NameAmicus Therapeutics
Listing DateMay 31, 2007
Issue Price15.00
Founded2002
CEOMr. Bradley L. Campbell
MarketNASDAQ
Employees517
Fiscal Year Ends12-31
Address47 Hulfish Street
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08542
Phone1-609-662-2000
Websitehttp://www.amicusrx.com
Company Executives
- Name
- Position
- Salary
- Bradley L. Campbell
- Director, President and Chief Executive Officer
- 8.20M
- Simon Nicolas Reade Harford
- Chief Financial Officer
- 2.98M
- Jeffrey P. Castelli, PhD
- Chief Development Officer
- 3.67M
- David M. Clark
- Chief People Officer
- 3.21M
- Ellen S. Rosenberg
- Chief Legal Officer, General Counsel and Corporate Secretary
- 4.08M
- Samantha Prout
- Chief Accounting Officer and Controller
- --
- Michael G. Raab
- Lead Independent Director and Chairman of the Board
- 426.25K
- Lynn Dorsey Bleil
- Independent Director
- 397.50K
- Michael A. Kelly
- Independent Director
- 391.25K
- Dr. Eiry W. Roberts, M.D.
- Independent Director
- 390.00K
- Glenn P. Sblendorio
- Independent Director
- 407.07K
- Burke W. Whitman
- Independent Director
- 391.25K
- Craig A. Wheeler
- Independent Director
- 398.50K
- Margaret G. McGlynn
- Independent Director
- 401.25K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.